ロード中...
LAG-3 expression in the inflammatory microenvironment of glioma
PURPOSE: Immune modulatory therapies including immune checkpoint inhibitors have so far failed to result in clinically meaningful efficacy in glioma. We aimed to investigate lymphocyte activation gene 3 (LAG-3), an inhibitory receptor on immune cells and target of second-generation immune checkpoint...
保存先:
| 出版年: | J Neurooncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8084780/ https://ncbi.nlm.nih.gov/pubmed/33651248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-021-03721-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|